TY  - GEN
AU  - Leith,C P
AU  - Kopecky,K J
AU  - Godwin,J
AU  - McConnell,T
AU  - Slovak,M L
AU  - Chen,I M
AU  - Head,D R
AU  - Appelbaum,F R
AU  - Willman,C L
TI  - Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study
SN  - 0006-4971
PY  - 1997///0603
KW  - ATP Binding Cassette Transporter, Subfamily B, Member 1
KW  - biosynthesis
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Antigens, CD
KW  - Antigens, CD34
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Chromosome Aberrations
KW  - Chromosome Disorders
KW  - Cytarabine
KW  - administration & dosage
KW  - Daunorubicin
KW  - Double-Blind Method
KW  - Drug Resistance, Multiple
KW  - genetics
KW  - Female
KW  - Granulocyte Colony-Stimulating Factor
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Leukemia, Promyelocytic, Acute
KW  - Male
KW  - Middle Aged
KW  - Neoplasms, Second Primary
KW  - Recombinant Proteins
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -